Advertisement

 

 

Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.

Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.
Author Information (click to view)

Rubio GA, Catanuto P, Glassberg MK, Lew JI, Elliot SJ,


Rubio GA, Catanuto P, Glassberg MK, Lew JI, Elliot SJ, (click to view)

Rubio GA, Catanuto P, Glassberg MK, Lew JI, Elliot SJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Surgery 2017 11 08() pii 10.1016/j.surg.2017.04.031

Abstract
BACKGROUND
Estrogen receptors can regulate growth in papillary thyroid cancer and may affect prognosis after menopause. This study examines changes of estrogen receptor subtype ratio expression in papillary thyroid cancer cell lines derived from pre- and postmenopausal women.

METHODS
Cells were harvested from papillary thyroid cancer and non-papillary thyroid cancer thyroid tissue (control) from pre- (n = 9) and postmenopausal women (n = 11). Protein expression of estrogen receptor α, estrogen receptor β, and phosphorylated extracellular signal-regulated kinase and protein kinase B were analyzed. Matrix metalloproteinase-2 activity was determined as a measure of tumor invasiveness. Mitochondrial retrograde signaling was altered with ethidium bromide to determine its effect on estrogen receptor α protein expression.

RESULTS
Estrogen receptor α expression was increased in postmenopausal papillary thyroid cancer cells compared with controls but was unchanged in premenopausal papillary thyroid cancer. Estrogen receptor β expression did not change in either group. Increased matrix metalloproteinase-2 activity was observed only in postmenopausal papillary thyroid cancer. Premenopausal papillary thyroid cancer cells demonstrated increased extracellular signal-regulated kinase and unchanged protein kinase B activation. Conversely, postmenopausal papillary thyroid cancer cells had decreased extracellular signal-regulated kinase and increased protein kinase B activation. Ethidium bromide treatment resulted in increased estrogen receptor α protein expression only in premenopausal papillary thyroid cancer cells.

CONCLUSION
Increased estrogen receptor α expression may be involved in papillary thyroid cancer aggressiveness after menopause. This process may be regulated by differential activation of intracellular pathways and differing sensitivities to mitochondrial signaling regulation. (Surgery 2017;160:XXX-XXX.).

Submit a Comment

Your email address will not be published. Required fields are marked *

sixteen − 14 =

[ HIDE/SHOW ]